rs78403836

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002087.4(GRN):​c.-7-320C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0509 in 152,334 control chromosomes in the GnomAD database, including 276 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.051 ( 276 hom., cov: 33)

Consequence

GRN
NM_002087.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.116

Publications

2 publications found
Variant links:
Genes affected
GRN (HGNC:4601): (granulin precursor) Granulins are a family of secreted, glycosylated peptides that are cleaved from a single precursor protein with 7.5 repeats of a highly conserved 12-cysteine granulin/epithelin motif. The 88 kDa precursor protein, progranulin, is also called proepithelin and PC cell-derived growth factor. Cleavage of the signal peptide produces mature granulin which can be further cleaved into a variety of active, 6 kDa peptides. These smaller cleavage products are named granulin A, granulin B, granulin C, etc. Epithelins 1 and 2 are synonymous with granulins A and B, respectively. Both the peptides and intact granulin protein regulate cell growth. However, different members of the granulin protein family may act as inhibitors, stimulators, or have dual actions on cell growth. Granulin family members are important in normal development, wound healing, and tumorigenesis. [provided by RefSeq, Jul 2008]
GRN Gene-Disease associations (from GenCC):
  • frontotemporal dementia and/or amyotrophic lateral sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • GRN-related frontotemporal lobar degeneration with Tdp43 inclusions
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • neuronal ceroid lipofuscinosis 11
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 17-44348838-C-G is Benign according to our data. Variant chr17-44348838-C-G is described in ClinVar as Benign. ClinVar VariationId is 1241013.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0611 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002087.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRN
NM_002087.4
MANE Select
c.-7-320C>G
intron
N/ANP_002078.1P28799-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRN
ENST00000053867.8
TSL:1 MANE Select
c.-7-320C>G
intron
N/AENSP00000053867.2P28799-1
GRN
ENST00000900927.1
c.-28-299C>G
intron
N/AENSP00000570986.1
GRN
ENST00000900929.1
c.-7-320C>G
intron
N/AENSP00000570988.1

Frequencies

GnomAD3 genomes
AF:
0.0509
AC:
7752
AN:
152216
Hom.:
277
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0214
Gnomad AMI
AF:
0.154
Gnomad AMR
AF:
0.0487
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0172
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0627
Gnomad OTH
AF:
0.0501
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0509
AC:
7751
AN:
152334
Hom.:
276
Cov.:
33
AF XY:
0.0520
AC XY:
3875
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0213
AC:
887
AN:
41586
American (AMR)
AF:
0.0486
AC:
744
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
379
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.0170
AC:
82
AN:
4832
European-Finnish (FIN)
AF:
0.107
AC:
1137
AN:
10606
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0626
AC:
4262
AN:
68032
Other (OTH)
AF:
0.0496
AC:
105
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
386
771
1157
1542
1928
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0223
Hom.:
14
Bravo
AF:
0.0471
Asia WGS
AF:
0.00751
AC:
26
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.9
DANN
Benign
0.62
PhyloP100
-0.12
PromoterAI
-0.011
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78403836; hg19: chr17-42426206; API